Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Happy power hour !
View:
Post by Sonboss on Aug 17, 2020 3:01pm

Happy power hour !

Glta
Comment by Redwiggler on Aug 17, 2020 3:40pm
Not much power in this hour but at least .225 seems to be holding up and the bid size @ .22 is good.
Comment by Jasper66 on Aug 17, 2020 4:06pm
This kind of volume attracts day traders. So not surprised we weren't able to keep our gains. The coming days will be the test. Hopefully anonymous is done with manipulating this stock. Only then will we start seeing a steady increase in share price.
Comment by Sonboss on Aug 17, 2020 4:07pm
Agree ! With the news flow , expected more!  I hold anyway! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities